Literature DB >> 12677440

Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study.

Kurt A Jellinger1.   

Abstract

Data on the relationship between Parkinson's disease (PD) and stroke have been conflicting, some studies showing a reduced risk of stroke during life, and others indicating an increased risk of stroke-related death. Consecutive cases (n=617) of autopsy-proven idiopathic PD (Lewy body disease of the brain stem type) and age-matched controls (n=535) were compared using current routine and immunohistochemical methods. The total frequency of cerebrovascular lesions (lacunes, amyloid angiopathy, white matter lesions, old and recent ischemic infarcts and hemorrhages) in PD (44.0%) was higher than in controls (32.8%), while acute, often fatal ischemic or hemorrhagic strokes were less frequent in parkinsonian patients (1.8% vs 2.6%). Like previous postmortem findings in a smaller cohort, these findings neither indicate a protective effect against stroke nor a greater susceptibility to death from stroke in the populations studied. Cognitive impairment in PD appears to be largely independent from coexistent vascular pathology except in cases with severe cerebrovascular lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12677440     DOI: 10.1007/s00401-003-0676-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

Review 1.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

2.  Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.

Authors:  M Petrou; C Davatzikos; M Hsieh; B R Foerster; R L Albin; V Kotagal; M L Müller; R A Koeppe; W H Herman; K A Frey; N I Bohnen
Journal:  Acad Radiol       Date:  2016-02-10       Impact factor: 3.173

Review 3.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

4.  Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases.

Authors:  M Plotkin; H Amthauer; S Quill; F Marzinzik; F Klostermann; S Klaffke; A Kivi; M Gutberlet; R Felix; A Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

5.  [The vascular Parkinson syndrome].

Authors:  K Jellinger
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 6.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

7.  Associations between cerebrovascular risk factors and parkinson disease.

Authors:  Benjamin R Kummer; Iván Diaz; Xian Wu; Ashley E Aaroe; Monica L Chen; Costantino Iadecola; Hooman Kamel; Babak B Navi
Journal:  Ann Neurol       Date:  2019-08-29       Impact factor: 10.422

8.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

9.  Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.

Authors:  I Huertas-Fernández; F J García-Gómez; D García-Solís; S Benítez-Rivero; V A Marín-Oyaga; S Jesús; M T Cáceres-Redondo; J A Lojo; J F Martín-Rodríguez; F Carrillo; P Mir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-14       Impact factor: 9.236

Review 10.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.